双黄连联合利巴韦林雾化吸入治疗急慢性咽炎的临床观察

The clinical effects of ShuangHuangLian plus Ribavirin atomization inhalation in the treatment of acute or chronic pharyngitis

目的观察双黄连联合利巴韦林雾化吸入用于急慢性咽炎的临床疗效。方法将急慢性咽炎患者101例随机分为对照组45例和治疗组56例。对照组仅予以常规对症治疗;治疗组在对照组治疗基础上加用双黄连联合利巴韦林雾化吸入治疗。治疗5d后观察并比较2组临床疗效。结果治疗组总有效率为96.4%,高于对照组的75.6%,差异有统计学意义(P<0.05)。结论双黄连联合利巴韦林雾化吸入用于急慢性咽炎疗效显著。

Objective To investigate the therapeutic effects of ShuangHuangLian plus ribavirin atomization inhalation in the treatment of acute or chronic pharyngitis.Methods 101 patients with acute or chr-onic pharyngitis were divided into the treatment group（n=45）and the control group（n=56）.The control group received conventional treatment,but the treatment group was based on routine treatment combined with ShuangHuangLian plus ribavirin atomization inhalation.After 5 days,the clinical efficacy of two groups were compareed.Results The effective rate of the treatment group was 96.4%;but the control group was 75.6%,there were significant difference between two groups（P0.05）.Conclusion ShuangHuangLian plus ribavirin atomization inhalation could obviously ameliorate symptoms of acute or chronic pharyngitis.